

Lunit Inc. is a cutting-edge company that leverages artificial intelligence (AI) to create innovative solutions for cancer detection and treatment. Their advanced AI technologies facilitate early cancer diagnosis and predict treatment outcomes, playing a crucial role in saving lives.
For customer service inquiries, please email Lunit Inc. at [email protected]. For more contact details, visit the contact us page(https://www.lunit.io/en/contact).
Lunit Inc. is committed to revolutionizing cancer care through AI.
For more information about Lunit Inc., please visit the about us page(https://www.lunit.io/en/company).
Follow Lunit Inc. on YouTube: https://www.youtube.com/channel/UC8LYLYa3cXOVZioI169pzOw
Lunit Inc. is a company specializing in AI technology for cancer screening and treatment, offering solutions for early cancer detection and treatment response prediction.
Healthcare professionals can integrate Lunit's AI software with their medical imaging systems for precise early-stage cancer detection and use Lunit's AI biomarkers to predict treatment responses.
Lunit's AI integrates with medical imaging systems to identify early-stage cancers, improving management and survival rates.
Lunit's AI biomarker predicts treatment responses, optimizing the efficacy of immunotherapy.
Yes, Lunit supports extensive research with over 200 studies and abstracts, driving the development of their AI solutions.
Lunit's AI technology includes cancer detection, immunotherapy biomarkers, a strong research foundation, and leading-edge AI innovations.
Lunit's AI is utilized in routine cancer care, implemented in hospitals like Inje University Paik Hospital, provided globally across 2,000+ sites, and partnered with research and business entities for precision oncology advancements.